Role of interoceptive fear and maladaptive attention and behaviors in the escalation of psychopathology-a network analysis.

The complex interplay of fear, attention, and behavior toward bodily sensations with psychopathological symptoms and how they mutually influence and potentially reinforce one another remains to be fully elucidated. In this study, we used a network analytical approach to unravel these complex interactions. Specifically, we aimed to identify central symptoms and etiologically relevant factors that might be associated with anxiety and depressive core symptoms. To this end, the following clusters were assessed in 791 adults: interoceptive fear, interoceptive attention, maladaptive behaviors related to bodily sensations, and core symptoms of anxiety and depression. This network was modeled using a Gaussian Graphical Model. Central variables (nodes) were identified using centrality indices and bridge analysis. Self-examination and attention to bodily sensations emerged as central nodes. Moreover, time spent paying attention to bodily sensations, fear of anxiety-related sensations, and self-examination were identified as central bridge nodes, that is, central nodes connecting psychopathologically relevant symptom clusters. The present study indicates that fear of bodily sensations, the amount of attention and time spent focusing on somatic sensations, and self-examination are central factors. The findings suggest potential targets for future longitudinal studies on the impact of these factors for the escalation of anxiety and depressive symptoms.

Central variables were identified through centrality indices and bridge analysisAttention to bodily sensations and self-examination were identified as central nodesFear of bodily sensations and self-examination emerged as central bridge nodesTime spent paying attention to body sensations also emerged as central bridge nodeResults suggest possible targets for future experimental and longitudinal research.

Current Limitations for the Assessment of the Role of the Gut Microbiome for Attention Deficit Hyperactivity Disorder (ADHD).

High throughput sequencing of bacterial 16S rRNA genes and metagenomes were applied to analyze complex microbial communities inhabiting the human gut and other body sites, and their role in numerous diseases. Studies in animals were important for elucidating the effects of the gut microbiota on the brain and behavior, and the responsible mechanisms. Recent studies in patients have identified bacterial taxa of the gut microbiome possibly impacting different neurological and psychiatric disorders including ADHD. Furthermore, antibiotic treatment of infections globally shape compositions of gut microbiota and might indirectly influence ADHD development. However, published studies revealed still partially incongruent results. Potential reasons for the still ill defined role of gut microbiota in ADHD comprise a) different study designs b) small number of patients c) different age groups analyzed d) inclusion of only treatment naive patients versus patients under medication e) differences of males versus females ratios and f) the heterogenous technology applied for microbiome sequence analysis. Furthermore, the complex interplay between the gut microbiome and individual host genetic factors requires much larger sample sizes and additional patient genome information. Alternative treatment options like probiotics or dietary interventions for ADHD therapy might offer new opportunities to prevent or treat this increasingly common disease. Clearly, further studies are needed to clarify molecular mechanisms imparting the gut brain axis as basis to modify commensal microbiota or their functions to target ADHD. The purpose of this review is to evaluate the most recent literature on the role of the gut microbiome in ADHD.